Efficacy and safety of ustekinumab in Behçet disease: Results from the prospective phase 2 STELABEC trial

Jonathan London, Alexis Régent, Jérémie Dion, Léa Jilet, M. Jachiet, Olivier Lidove, Fleur Cohen‐Aubart, S. Aractingi, Sarah Guégan, Jean‐Loup Pennaforte, Hendy Abdoul, Xavier Puéchal, Benjamin Terrier

2021Journal of the American Academy of Dermatology22 citationsDOI

Topics & Concepts

MedicineUstekinumabBehcet's diseaseInternal medicineClinical endpointProspective cohort studyRegimenGastroenterologyDermatologyRandomized controlled trialDiseaseAdalimumabOcular Diseases and Behçet’s SyndromeOtitis Media and Relapsing Polychondritis